Cellectar Biosciences, Inc. Debt Conversion, Converted Instrument, Amount
Cellectar Biosciences, Inc. (CLRB) reported Debt Conversion, Converted Instrument, Amount of $0 for the 12-month period ending 2015-12-31, per its 10-K/A filed 2016-10-20.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2016-10-20
- Cellectar Biosciences, Inc. debt conversion, converted instrument, amount for the quarter ending 2015-12-31 was $0.00.
- Cellectar Biosciences, Inc. debt conversion, converted instrument, amount for the quarter ending 2014-12-31 was -$9.00.
- Cellectar Biosciences, Inc. debt conversion, converted instrument, amount for the quarter ending 2014-09-30 was $426.44K.
- Cellectar Biosciences, Inc. debt conversion, converted instrument, amount for the quarter ending 2014-06-30 was $24.00.
- Cellectar Biosciences, Inc. debt conversion, converted instrument, amount for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- Cellectar Biosciences, Inc. debt conversion, converted instrument, amount for fiscal 2014 was $4.17M.
- Cellectar Biosciences, Inc. debt conversion, converted instrument, amount for fiscal 2013 was $0.00.
| Period end | Debt Conversion, Converted Instrument, Amount 0 month | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-10-20 | $0.00 10-K/A · filed 2016-10-20 | |||
| 2015-09-30 | $0.00 10-Q · filed 2015-11-12 | ||||
| 2014-12-31 | -$9.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-10-20 | $426.44K derived: sum of 2 quarters · filed 2016-10-20 | $426.46K derived: sum of 3 quarters · filed 2016-10-20 | $4.17M 10-K/A · filed 2016-10-20 | |
| 2014-09-30 | $426.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $426.47K derived: sum of 2 quarters · filed 2015-11-12 | $4.17M 10-Q · filed 2015-11-12 | $4.17M derived: sum of 4 quarters · filed 2015-11-12 | |
| 2014-06-30 | $24.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $3.75M 10-Q · filed 2014-08-04 | $3.75M derived: sum of 3 quarters · filed 2015-05-20 | ||
| 2014-03-31 | $3.75M 10-Q · filed 2014-05-14 | $3.75M derived: sum of 2 quarters · filed 2015-05-20 | |||
| 2014-02-05 | $3.75M 10-Q · filed 2015-05-20 | ||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-20 | $0.00 10-K · filed 2015-05-20 | |||
| 2013-09-30 | $0.00 10-Q · filed 2015-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |